#botsfightms — Public Fediverse posts

I just moved @gregory_ms from Med-Mastodon to the main Mastodon.social. Expect some glitches, again. 😬

#MSchat #BotsFightMS #multipleSclerosis #Neurology

To be transparent, we added a new page listing all the data sources where @gregoryMS searches for articles and clinical trials.
https://gregory-ms.com/sources/

#MSchat #botsFightMS #MultipleSclerosis #academic #research #openscience #opensource

@gregoryMS was having issues posting new #papers and #ClinicalTrials for #MultipleSclerosis. It's working again! And have you seen the site lately? We made a lot of improvements and will have more coming. https://gregory-ms.com/ #opensource #ai #health #research #BotsFightMS

Action observation combined with motor imagery of the upper extremities for people with multiple sclerosis

http://drks.de/search/en/trial/DRKS00036270

#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS

🧠⚡ World #MultipleSclerosis Day and @gregoryMS brings hope!

Our latest upgrade, co-built with Nova SBE, delivers sharper algorithms, multi-subject support & per-topic models (“MS + DMTs”, “MS + Myelin”). Less noise & quicker insights for researchers, clinicians, patients & carers.

Please boost so more people hear on #WorldMSDay.
Details ➡️ https://gregory-ms.com/post/gregory-ai-update-better-algorithms-ms-researchers/
Support ➡️ https://lnkd.in/df3aZkeH

#MSResearch #AIforGood #BotsFightMS #mschat

Educational Programs Based on Healthy Habits to Improve Quality of Life and Psychosocial Profile in Women with Neurodegenerative Diseases: the ADVICE Protocol Study (Phase 2)

https://clinicaltrials.gov/study/NCT06884579?cond=Multiple+Sclerosis

#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS

A Randomized, Double-blind, Parallel-group Study to Compare Pharmacokinetics, Pharmacodynamics, Clinical Effects, and Safety between ABP 692 and Ocrevus® (Ocrelizumab) in Subjects with Relapsing-remitting Multiple Sclerosis

https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2024-512914-16-00

#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS

A single-arm, prospective, multicentre, open-label study to evaluate ofatumumab treatment effectiveness and patient-reported outcomes (PRO) in patients with relapsing multiple sclerosis (RMS) transitioning from fumarate-based RMS approved therapies or fingolimod.

https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2023-507493-41-00

#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS

TANDem-2: Closing the Gap to Interventions for TAND

https://clinicaltrials.gov/study/NCT06879665?cond=Multiple+Sclerosis

#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS

Improving Cognitive Recovery in Multiple Sclerosis

https://clinicaltrials.gov/study/NCT06877273?cond=Multiple+Sclerosis

#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS

Effect of Training With Reaction Systems on Cognitive Functions in Individuals With Multiple Sclerosis

https://clinicaltrials.gov/study/NCT06874764?cond=Multiple+Sclerosis

#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS

Reliability and Validity of the Turkish Version of General Sleep Disturbance Scale (GSDS-T) in Multiple Sclerosis

https://clinicaltrials.gov/study/NCT06875908?cond=Multiple+Sclerosis

#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS

Evaluation of the Efficacy of Transcranial Direct Current Stimulation in Reducing Fatigue and Improving Quality of Life in Patients With Multiple Sclerosis: A Randomized Clinical Trial

https://clinicaltrials.gov/study/NCT06873464?cond=Multiple+Sclerosis

#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS

P3-IMU-838-RMS-01 - A Multi-Center, Randomized, Double-Blinded Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of IMU-838 versus Placebo in Adults with Relapsing Multiple Sclerosis (ENSURE-1)

https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2024-514618-11-00

#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS

A Phase 3, Multicenter, Double Blind, Active-Controlled Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Oral Ozanimod Compared to Oral Fingolimod in Children and Adolescents with Relapsing Remitting Multiple Sclerosis

https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2022-501332-42-00

#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS

Telerehabilitation for Multiple Sclerosis

https://clinicaltrials.gov/study/NCT06871072?cond=Multiple+Sclerosis

#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS

FIT-ATOMIC Exercise Feasibility Trial

https://clinicaltrials.gov/study/NCT06870968?cond=Multiple+Sclerosis

#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS

Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab

https://clinicaltrials.gov/study/NCT06869785?cond=Multiple+Sclerosis

#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS

A Study of LCAR-AIO CAR-T Cells for Treating Relapsed/Refractory Neurological Autoimmune Diseases

https://clinicaltrials.gov/study/NCT06869278?cond=Multiple+Sclerosis

#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS

Nerve Root Block in Spasticity

https://clinicaltrials.gov/study/NCT06868342?cond=Multiple+Sclerosis

#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS

Frequency of FCGR3A Gene Polymorphisms in Patients with Neuromyelitis Optica Spectrum Disorders, Anti-oligodendrocyte Myelin Protein Antibody Disease, and Multiple Sclerosis.

https://clinicaltrials.gov/study/NCT06865274?cond=Multiple+Sclerosis

#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS

Exploration of Novel Imaging Biomarkers on OCT for Ublituximab Treatment Response in Multiple Sclerosis

https://clinicaltrials.gov/study/NCT06864936?cond=Multiple+Sclerosis

#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS

A Palliative Care Model Impact on Knowledge and Attitudes

https://clinicaltrials.gov/study/NCT06860932?cond=Multiple+Sclerosis

#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS

A Canadian Study of Persistence on Ofatumumab Using Patient Support Program Data

https://clinicaltrials.gov/study/NCT06854341?cond=Multiple+Sclerosis

#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS

Diet quality among people with multiple sclerosis using personalised digital nutrition education

https://anzctr.org.au/ACTRN12625000168459.aspx

#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS

Spinal cord magnetic resonance imaging in multiple sclerosis

https://www.isrctn.com/ISRCTN17412521

#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS

effect of self-care training on multiple sclerosis patients

https://irct.behdasht.gov.ir/trial/81082

#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS

An MRI study of the causal association mechanism of functional brain

https://www.chictr.org.cn/showproj.html?proj=253674

#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS

A clinical study to compare the efficacy of add-on Ayurveda treatment versus Allopathy treatment in Multiple sclerosis

http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=80933

#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS

The effects of lisdexamphetamine dimesylate on multiple sclerosis patients with fatigue

https://irct.behdasht.gov.ir/trial/80601

#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS